The tumor promoting effect of the HCV transgene may be explained both by upregulation of pro-tumorigenic genes as Ubd, Erbb4, Nrg1, Ndrg1, Styk1 (Table 3), and by evasion of host defense response by viral proteins [45], [46]. The gene discussed is ERBB4; the disease is neoplasm.